Back to search

Article

Farnesyl Transferase Inhibition for the Treatment of Tauopathies

2018-12-18

Abstract excerpt

Tau inclusions are a shared feature of many neurodegenerative conditions and tau mutations lead to frontotemporal dementia. Approaches to treatment of these conditions have focused directly on the tau protein by targeting its post-translational modifications, its levels and its tendency to aggregate. We discovered a novel regulatory pathway for tau degradation that operates through the Rhes protein, a GTPase. Rhes...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
349089c5-6777-51e2-8328-c168e93a1324
DOI
10.1101/500801
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Farnesyl Transferase Inhibition for the Treatment of TauopathiesDOI 10.1101/500801
Select a neighboring publication to make it the new centre.